While physicians operating through MPCs are primarily focused on patient care, those engaged in systematic experimental development to overcome technological uncertainties, such as developing novel AI algorithms, creating new digital health platforms, or conducting clinical R&D, may be eligible to claim SR&ED tax credits. Although the CRA does recognize these types of activities as potentially eligible, your eligibility depends on whether your MPC is the entity directly conducting and financing the research. This makes it essential to have clear agreements in place that define your MPC’s role in the research, along with robust documentation that clearly distinguishes between standard clinical practice and other activities such as research, teaching, and administration. At Ayming, we help physicians like you navigate this complexity, maximize SR&ED claims, and reinvest in what matters most, driving better patient outcomes.
MPC
Addressing the key challenges
Your Medical Professional Corporations (MPCs) can face significant challenges when claiming SR&ED tax credits. Unclear roles, collaborative arrangements, and funding complexities often create hurdles, and disputes may arise over whether your MPC, or the affiliated hospital or university, actually conducted the research. The CRA has sometimes denied claims, arguing that physicians with academic or hospital appointments perform research for the institution, not the MPC. Alternative funding payments can also reduce eligible expenditures if classified as government assistance. That’s where Ayming comes in, we guide you through these complexities to maximize your claim and secure the funding you deserve.
How we can help maximize your results
Medical Professional Corporations (MPCs) are at the forefront of clinical innovation, advancing new diagnostics, treatments, and care models. Yet many physicians overlook the significant funding available through Canada’s SR&ED program. Whether you’re testing new protocols, integrating novel technologies, or conducting collaborative research with hospitals and universities, your MPC may be entitled to substantial tax credits that can fuel growth and reinvestment in patient care.
At Ayming, we specialize in helping MPCs identify, structure, and defend their SR&ED claims. From clarifying eligibility in complex hospital or university collaborations, to navigating compensation models and provincial funding structures, we ensure your work is recognized, compliant, and financially maximized.
Our comprehensive support includes:
- Eligibility and Structuring Guidance: One of the first steps in a successful SR&ED claim is determining whether the work performed qualifies under the CRA’s criteria, and more importantly, whether the MPC is the appropriate entity to file the claim. Our experienced consultants will help assess the eligibility of research activities and clarify the ownership of the work, particularly in collaborative environments involving hospitals and universities. Beyond compliance, our consultants will provide guidance on structuring the relationship between the MPC and affiliated institutions to ensure that the MPC, not the hospital or university, is recognized as the entity conducting and financing the SR&ED work.
- Documentation and Claim Preparation: Our consultants will assist MPCs in collecting the necessary technical and financial records to support their claims and advise on best practices to improve documentation processes to optimize future filings. This includes best practices in tracking time spent on research, outlining project objectives, and demonstrating the presence of systematic investigation or experimentation. We will also prepare CRA-compliant technical narratives and calculate eligible expenditures, including salary allocations and overhead, ensuring that the claim is complete, defensible, and maximized.
- Funding and Financial Analysis: Depending in which province you are located, the physician compensation models may go beyond traditional fee-for-service, your province may offer Alternative payments programs which can complicate SR&ED eligibility. Our seasoned consultants will help assess how these and other funding sources impact your claim, particularly when payments may be classified as government assistance, properly treat these amounts within the claim and ensure that any required offsets are applied appropriately. This careful analysis is crucial to maintaining compliance and avoiding reductions to eligible expenditures.
- Audit defense and compliance strategy: The SR&ED program is governed by complex tax rules and evolving CRA interpretations. Ayming stays current with guidance and policy updates, helping you navigate these complexities with confidence. Your SR&ED consultant will provide early warnings on audit trends and policy shifts that affect the MPC sector. In the event of a CRA audit, we manage the end-to-end audit response to defend the claim and address any concerns.
Whether you’re pioneering new treatments, refining medical procedures, or exploring advanced technologies, our consultants help translate your clinical innovation into impactful SR&ED claims. These claims are designed to maximize your financial return and ensure compliance with CRA requirements. By recovering more through SR&ED, your Medical Professional Corporation can reinvest directly into growth, research, and most importantly, advancing patient outcomes.
We help Medical Professional Corporations (MPCs) unlock the full potential of Quebec’s Incentive Deduction for the Commercialization of Innovations (IDCI). This program can reduce the provincial tax rate on eligible income from qualified intellectual property assets (QIPAs) from 11.5% to as low as 2%, rewarding corporations that conduct R&D in Quebec and commercialize their innovations locally or internationally.
By strategically combining this incentive with investments in equipment, facilities, and clinical or technological processes, MPCs can increase operational efficiency, accelerate the adoption of innovative solutions, and maximize the value of their intellectual property.
Our team of experts ensures these incentives are fully optimized and compliant, empowering MPCs to scale innovation, strengthen their competitive advantage, and make the most of every R&D dollar.
Shaping the future of Medical Professional Corporations
Our latest thinking helps the industry navigate change with confidence, from emerging trends to future-ready solutions.
